[EN] METHODS OF TREATMENT OF AMYLOIDOSIS USING ASPARTYL-PROTEASE INIHIBITORS<br/>[FR] PROCEDES DE TRAITEMENT D'AMYLOIDOSE UTILISANT DES INHIBITEURS DE PROTEASE ASPARTYLE
申请人:ELAN PHARM INC
公开号:WO2005070407A1
公开(公告)日:2005-08-04
The invention relates to acetyl 2-hydroxy-1,3-diaminospirocyclohexanes and derivatives thereof that are useful in treating diseases, disorders, and conditions associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and conditions associated with abnormal deposition of A-beta protein.
ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC APPARATUS
申请人:IDEMITSU KOSAN CO., LTD.
公开号:US20210005826A1
公开(公告)日:2021-01-07
An organic electroluminescence device comprising a cathode, an anode and an organic layer disposed between the cathode and the anode, wherein the organic layer comprises a fluorescent emitting layer and the fluorescent emitting layer comprises a first compound, a second compound having a hole mobility larger than that of the first compound, and a dopant material showing a fluorescent spectrum with a half width of 30 nm or less; and an organic electroluminescence device comprising a cathode, an anode and an organic layer disposed between the cathode and the anode, wherein the organic layer comprises a fluorescent emitting layer and the fluorescent emitting layer comprises a first compound, a third compound having an affinity larger than that of the first compound, and a dopant material showing a fluorescent spectrum with a half width of 30 nm or less and the content of the third compound in the fluorescent emitting layer is less than that of the first compound in the fluorescent emitting layer are excellent in their performance.
[EN] SUBSTITUTED UREA AND CARBAMATE, PHENACYL-2-HYDROXY-3-DIAMINOALKANE, AND BENZAMIDE-2-HYDROXY-3-DIAMINOALKANE ASPARTYL-PROTEASE INHIBITORS<br/>[FR] UREE ET CARBAMATE SUBSTITUES, PHENACYL-2-HYDROXY-3-DIAMINOALCANE, ET BENZAMIDE-2-HYDROXY-3-DIAMINOALCANE INHIBITEURS D'ASPARTYL-PROTEASE
申请人:ELAN PHARM INC
公开号:WO2005087215A1
公开(公告)日:2005-09-22
The invention relates to acetyl 2-hydroxy-1,3-diaminospirocyclohexanes and derivatives thereof that are useful in treating at least one disease, disorder, and condition associated with amyloidosis. Amyloidosis refers to a collection of diseases, disorders, and condition associated with abnormal deposition of A-beta protein.
ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
申请人:IDEMITSU KOSAN CO., LTD.
公开号:US20210005825A1
公开(公告)日:2021-01-07
An organic electroluminescence device comprising a cathode, an anode and an organic layer disposed between the cathode and the anode, wherein the organic layer comprises a fluorescent emitting layer and the fluorescent emitting layer comprises at least one first compound selected from the compounds represented by formulae (19), (21), (22), and (23), a second compound selected from the compounds represented by formula (3a), and a dopant material selected from the compounds represented by formulae (D1) and (D2) is excellent in its performance.